COVID-19:使用创新的恒定流冠层在产生气溶胶的呼吸疗法期间对医疗保健工人的风险降至最低
- PMID:32312865
- PMCID:PMC7173679
- DOI:10.1183/13993003.01017-2020
COVID-19:使用创新的恒定流冠层在产生气溶胶的呼吸疗法期间对医疗保健工人的风险降至最低
Abstract
An innovative constant flow canopy enables noninvasive respiratory support with minimal risk of healthcare worker infection
利益冲突声明
Conflict of interest: Y. Adir received personal fees for lecturing and/or consulting from Actelion, Boehringer Ingelheim, Teva, Bayer, GSK, Roche, Novartis, AstraZeneca, Kamada and UT Pharmaceuticals, and research grants from Actelion, Bayer, Boehringer Ingelheim andgsk。利益冲突:O。Segol无话可说。利益冲突:D。Kompaniets没有什么可披露的。利益冲突:H。Ziso报告说,以色列创新管理局已向塔玛尔机器人有限公司授予了资金,这些资金以及我们投资者分配的资金被用来开发本文介绍的系统;H. Ziso拥有美国临时专利申请编号63/001,562,以色列专利申请编号273616,标题为:“可在医务人员和其他人免受感染疾病传播的诉讼”和美国临时专利申请编号62/62/994,614标题为:“用于保护医务人员和其他人免受传染病传播的便携式患者引擎盖系统”;并想指出:1)作者是Tamar Robotics Ltd的雇员,该雇员开发了本文中作为研发副总裁介绍的系统;2)作者是Tamar Robotics Ltd的联合创始人,并拥有该公司的股份(不到6%);3)Tamar Niv呼吸解决方案有限公司将来可能会出售该产品,如果将来进行此类销售,作者将获得股息或特许权使用费。利益冲突:Y. Yaffe无话可说。 Conflict of interest: I. Bergman has nothing to disclose. Conflict of interest: E. Hassidov reports that the Israeli innovation authority have granted funds to Tamar Robotics Ltd, such funds along with funds allocated by our investors were used to develop the system presented in this paper; E. Hassidov has a US Provisional Patent Application number 63/001,562, Israel Patent Application number 273616, entitled: “Portable Patient Hood System For Protection Of Medical Staff And Others From Infectious Disease Transmission” pending, and a US Provisional Patent Application number 62/994,614 entitled: “Portable Patient Hood System For Protection Of Medical Staff And Others From Infectious Disease Transmission” pending; and would like to state that: 1) the author is a part-time employee of Tamar Robotics Ltd that developed the system presented in the paper; 2) the author's brother is Noam Hassidov, CEO of Tamar Robotics Ltd; 3) the author is a fifth year student in the Bar Illan medical school in Israel; 4) the author works once a week in the ER of Carmel Medical Center as an assistant physician; 5) the author has no holdings in Tamar Robotics or any other companies related to the system presented in this paper; 6) Tamar Niv Breathing Solutions Ltd may sell this product in the future. Conflict of interest: A. Eden has nothing to disclose.
数字
Similar articles
-
在高级气道管理期间,可针对Covid-19的液滴和气溶胶传输的简单定制设备。残疾人护理。2020 Jun 8; 24(1):319。doi:10.1186/s13054-020-02985-5。 残疾人护理。2020。 PMID:32513230 Free PMC article. 不abstract available.
-
Management of Coronavirus Disease 2019 Intubation Teams.A实践。2020 Jun; 14(8):E01263。doi:10.1213/xaa.0000000000001263。 A实践。2020。 PMID:32643908 Free PMC article.
-
气溶胶生成的耳鼻喉科程序以及在19009年大流行期间对PPE增强的需求:文献综述。j耳鼻喉头颈外侧。2020年5月11日; 49(1):29。doi:10.1186/s40463-020-00424-7。 j耳鼻喉头颈外侧。2020。 PMID:32393346 Free PMC article. 审查。
-
COVID-19的通风患者的气管切开术。Ann Surg。2020 Jul; 272(1):E30-E32。doi:10.1097/sla.0000000000003956。 Ann Surg。2020。 PMID:32379079 Free PMC article. 不abstract available.
-
Particle sizes of infectious aerosols: implications for infection control.柳叶刀呼吸医学。2020年9月; 8(9):914-924。doi:10.1016/s2213-2600(20)30323-4。EPUB 2020年7月24日。 柳叶刀呼吸医学。2020。 PMID:32717211 Free PMC article. 审查。
被引用4articles
-
A COVID-19 Airway Management Innovation with Pragmatic Efficacy Evaluation: The Patient Particle Containment Chamber.Ann Biomed Eng。2020年10月; 48(10):2371-2376。doi:10.1007/s10439-020-02599-6。EPUB 2020 8月27日。 Ann Biomed Eng。2020。 PMID:32856180 Free PMC article.
-
气道程序的障碍物围墙的好处和局限性。J Cardiothorac Vasc Anesth。2020年7月16日:S1053-0770(20)30666-2。doi:10.1053/j.jvca.2020.07.036。在线印刷。 J Cardiothorac Vasc Anesth。2020。 PMID:32782192 Free PMC article. 不abstract available.
-
Use of a Novel Negative-Pressure Tent During Bedside Tracheostomy in COVID-19 Patients.神经关怀。2020年10月; 33(2):597-603。doi:10.1007/s12028-020-01068-1。EPUB 2020 8月7日。 神经关怀。2020。 PMID:32770341 Free PMC article.
-
COVID19期间的肿瘤学护理中的病变。口服Oncol。2020 Aug;107:104782. doi: 10.1016/j.oraloncology.2020.104782. Epub 2020 May 11. 口服Oncol。2020。 PMID:32414644 Free PMC article. 不abstract available.
参考
-
- Critical care committee of Chinese Association of Chest Physician; Respiratory and critical care group of Chinese Thoracic Society; Respiratory care group of Chinese Thoracic Society. [Conventional respiratory support therapy for severe acute respiratory infections (SARI): clinical indications and nosocomial infection prevention and control]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43: 189–194. doi:10.3760/cma.j.issn.1001-0939.2020.03.010 -DOI-PubMed
出版类型
MeSH terms
Substances
补充概念
LinkOut - more resources
Full Text Sources
Medical